Advertisement
Journal Home
Search for

151 Periodical Search Results

You searched for "vascular endothelial growth factor" OR "vascular endothelial growth factor a" within Lung Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 151 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis , 26 March 2009
    Barbara Bonnesen, Helle Pappot, Julie Holmstav, Birgit Guldhammer Skov
    Lung Cancer
    December 2009 (Vol. 66, Issue 3, Pages 314-318)
    Abstract | Full Text | Full-Text PDF (742 KB)

  1. P-007 Vascular endothelial growth factor-A as a predicting factor of clinical outcome in non-small cell lung cancer
    F. Bertin, V. Gazaille, F. Sturtz, M. Laskar, B. Melloni
    Lung Cancer
    July 2005 (Vol. 49Supplement 2, Page S116)
    Full-Text PDF (149 KB)

  1. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients , 27 March 2009
    Magdalena Bieniasz, Katarzyna Oszajca, Mak Eusebio, Jacek Kordiak, Jacek Bartkowiak, Janusz Szemraj
    Lung Cancer
    December 2009 (Vol. 66, Issue 3, Pages 319-326)
    Abstract | Full Text | Full-Text PDF (341 KB)

  1. Thromboxane receptor α mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells Corrected Proof, 26 October 2009
    Jingyan Wei, Weili Yan, Xiuling Li, Yunfei Ding, Hsin-Hsiung Tai
    Lung Cancer
    DOI: 10.1016/j.lungcan.2009.09.009
    Abstract | Full Text | Full-Text PDF (657 KB)

  1. Serum endostatin correlates with progression and prognosis of non-small cell lung cancer
    Makoto Suzuki, Toshihiko Iizasa, Eitetu Ko, Masayuki Baba, Yukio Saitoh, Kiyoshi Shibuya, Yasuo Sekine, Shigetoshi Yoshida, Kenzo Hiroshima, Takehiko Fujisawa
    Lung Cancer
    January 2002 (Vol. 35, Issue 1, Pages 29-34)
    Abstract | Full Text | Full-Text PDF (101 KB)

  1. Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma
    Hedy L Kindler
    Lung Cancer
    August 2004 (Vol. 45Supplement, Pages S125-S127)
    Abstract | Full Text | Full-Text PDF (69 KB)

  1. Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines
    Hartmut Kuhn, Jana Konrad, Silke Holtz, Aida Salameh, Christian Gessner, Stefan Hammerschmidt, Hubert Wirtz
    Lung Cancer
    November 2006 (Vol. 54, Issue 2, Pages 149-153)
    Abstract | Full Text | Full-Text PDF (198 KB)

  1. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer
    Michael I. Koukourakis, Dimitrios Papazoglou, Alexandra Giatromanolaki, George Bougioukas, Efstratios Maltezos, Efthimios Siviridis
    Lung Cancer
    December 2004 (Vol. 46, Issue 3, Pages 293-298)
    Abstract | Full Text | Full-Text PDF (184 KB)

  1. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts
    Jin-Hyuk Choi, Hugh Chul Kim, Ho-Yeong Lim, Dong Ki Nam, Hyun Soo Kim, Jong Wook Yi, Mison Chun, Young Taek Oh, Seunghee Kang, Kwang Joo Park, Sung Chul Hwang, Yi Hyeong Lee, Myung Ho Hahn
    Lung Cancer
    August 2001 (Vol. 33, Issue 2, Pages 171-179)
    Abstract | Full Text | Full-Text PDF (124 KB)

  1. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer
    Vienna Ludovini, Vanesa Gregorc, Lorenza Pistola, Zhasmina Mihaylova, Irene Floriani, Samir Darwish, Fabrizio Stracci, Francesca Romana Tofanetti, Massimiliano Ferraldeschi, Luciana Di Carlo, Mark Ragusa, Giuliano Daddi, Maurizio Tonato
    Lung Cancer
    October 2004 (Vol. 46, Issue 1, Pages 77-85)
    Abstract | Full Text | Full-Text PDF (239 KB)

  1. Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer
    Srikala S. Sridhar, Frances A. Shepherd
    Lung Cancer
    December 2003 (Vol. 42, Issue 2, Supplement, Pages 81-91)
    Abstract | Full Text | Full-Text PDF (227 KB)

  1. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer , 13 February 2008
    A. Katsabeki-Katsafli, T. Kerenidi, K. Kostikas, E. Dalaveris, T.S. Kiropoulos, E. Gogou, A.I. Papaioannou, K.I. Gourgoulianis
    Lung Cancer
    May 2008 (Vol. 60, Issue 2, Pages 271-276)
    Abstract | Full Text | Full-Text PDF (345 KB)

  1. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer , 27 August 2008
    Ri Cui, Fumiyuki Takahashi, Rina Ohashi, Masakata Yoshioka, Tao Gu, Ken Tajima, Takeshi Unnoura, Shinichiro Iwakami, Michihiro Hirama, Toshiji Ishiwata, Akihiko Iwase, Kazuhisa Takahashi
    Lung Cancer
    March 2009 (Vol. 63, Issue 3, Pages 368-374)
    Abstract | Full Text | Full-Text PDF (862 KB)

  1. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)
    Eckart Laack, Antje Scheffler, Iris Burkholder, Ina Boeters, Birte Andritzky, Gunter Schuch, Michael Görn, Gaby Vohwinkel, Lutz Edler, Walter Fiedler, Dieter Kurt Hossfeld
    Lung Cancer
    October 2005 (Vol. 50, Issue 1, Pages 51-58)
    Abstract | Full Text | Full-Text PDF (244 KB)

  1. Angiogenesis inhibitors in the treatment of lung cancer
    Frances A. Shepherd
    Lung Cancer
    December 2001 (Vol. 34Supplement 3, Pages 81-89)
    Abstract | Full Text | Full-Text PDF (95 KB)

  1. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer
    G Cox, R.A Walker, A Andi, W.P Steward, K.J O'Byrne1
    Lung Cancer
    1 September 2000 (Vol. 29, Issue 3, Pages 169-177)
    Abstract | Full Text | Full-Text PDF (254 KB)

  1. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression
    Julie Litz, G. Sakuntala Warshamana-Greene, Geoffrey Sulanke, Kenneth E. Lipson, Geoffrey W. Krystal
    Lung Cancer
    December 2004 (Vol. 46, Issue 3, Pages 283-291)
    Abstract | Full Text | Full-Text PDF (328 KB)

  1. Towards a biological staging model for operable non-small cell lung cancer
    K.J O'Byrne, G Cox, D Swinson, D Richardson, J.G Edwards, J Lolljee, A Andi, M.I Koukourakis, A Giatromanolaki, K Gatter, A.L Harris, D Waller, J.L Jones
    Lung Cancer
    December 2001 (Vol. 34Supplement 2, Pages S83-S89)
    Abstract | Full Text | Full-Text PDF (161 KB)

  1. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis
    Daniel T. Merrick, Jerry Haney, Sheila Petrunich, Michio Sugita, York E. Miller, Robert L. Keith, Tim C. Kennedy, Wilbur A. Franklin
    Lung Cancer
    April 2005 (Vol. 48, Issue 1, Pages 31-45)
    Abstract | Full Text | Full-Text PDF (798 KB)

  1. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer
    Takashi Seto, Masahiko Higashiyama, Hiroko Funai, Fumio Imamura, Kazutsugu Uematsu, Nobuhiko Seki, Kenji Eguchi, Takeharu Yamanaka, Yukito Ichinose
    Lung Cancer
    July 2006 (Vol. 53, Issue 1, Pages 91-96)
    Abstract | Full Text | Full-Text PDF (248 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 151 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement